Denali Therapeutics (DNLI) Change in Account Payables (2017 - 2026)
Denali Therapeutics (DNLI) reported Change in Account Payables of $3.9 million for Q1 2026, up 246.84% year-over-year from $1.1 million in Q1 2025, and up 213.7% on a QoQ basis from -$3.4 million in Q4 2025.
Denali Therapeutics (DNLI) has 10 years of Change in Account Payables data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Change in Account Payables rose 246.84% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 million (up 45.24% YoY) and the FY2025 annual result came in at -$7.5 million, down 623.31% from the prior year.
- Change in Account Payables rose to $3.9 million in Q1 2026 per DNLI's latest filing, from -$3.4 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.8 million in Q2 2023 and bottomed at -$4.4 million in Q3 2024.
- The 5-year median for Change in Account Payables is $839000.0 (2022), against an average of $146882.4.
- The widest annual swing landed in 2022, when Change in Account Payables plunged 2098.72%; it then jumped 469.01% in 2023.
- Tracing DNLI's Change in Account Payables over 5 years: stood at -$1.7 million in 2022, then declined by 21.34% to -$2.1 million in 2023, then jumped by 161.8% to $1.3 million in 2024, then plunged by 365.01% to -$3.4 million in 2025, then jumped by 213.7% to $3.9 million in 2026.
- Per Business Quant, the three latest DNLI Change in Account Payables figures stand at $3.9 million (Q1 2026), -$3.4 million (Q4 2025), and -$4.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | 3.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.88 Mn |
| Mar 31, 2026 | 3.88 Mn |
| Dec 31, 2025 | -3.41 Mn |
| Dec 31, 2025 | -3.41 Mn |
| Sep 30, 2025 | -4.07 Mn |
| Sep 30, 2025 | -4.07 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | -2.64 Mn |
| Mar 31, 2025 | -2.64 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | -4.37 Mn |
| Sep 30, 2024 | -4.37 Mn |
| Jun 30, 2024 | 3.89 Mn |
| Jun 30, 2024 | 3.89 Mn |
| Mar 31, 2024 | 635,000.00 |
| Mar 31, 2024 | 635,000.00 |
| Dec 31, 2023 | -2.08 Mn |
| Dec 31, 2023 | -2.08 Mn |
| Sep 30, 2023 | -3.96 Mn |
| Sep 30, 2023 | -3.96 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Jun 30, 2023 | 4.77 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | -1.72 Mn |
| Dec 31, 2022 | -1.72 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 839,000.00 |
| Jun 30, 2022 | 839,000.00 |
| Mar 31, 2022 | 1.25 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | -78,000.00 |
| Dec 31, 2021 | -78,000.00 |
| Sep 30, 2021 | 782,000.00 |
| Sep 30, 2021 | 782,000.00 |
| Jun 30, 2021 | 2.38 Mn |
| Jun 30, 2021 | 2.38 Mn |
| Mar 31, 2021 | 623,000.00 |
| Mar 31, 2021 | 623,000.00 |
| Dec 31, 2020 | -1.77 Mn |
| Dec 31, 2020 | -1.77 Mn |
| Sep 30, 2020 | 891,000.00 |
| Sep 30, 2020 | 891,000.00 |
| Jun 30, 2020 | -452,000.00 |
| Jun 30, 2020 | -452,000.00 |
| Mar 31, 2020 | -292,000.00 |
| Mar 31, 2020 | -292,000.00 |
| Sep 30, 2019 | 466,000.00 |
| Sep 30, 2019 | 466,000.00 |
| Jun 30, 2019 | -662,000.00 |
| Jun 30, 2019 | -662,000.00 |
| Mar 31, 2019 | 1.97 Mn |
| Mar 31, 2019 | 1.97 Mn |
| Dec 31, 2018 | -1.76 Mn |
| Dec 31, 2018 | -1.76 Mn |
| Sep 30, 2018 | -5.86 Mn |
| Sep 30, 2018 | -5.86 Mn |
| Jun 30, 2018 | 8.05 Mn |
| Jun 30, 2018 | 8.05 Mn |
| Mar 31, 2018 | -951,000.00 |
| Mar 31, 2018 | -951,000.00 |
| Dec 31, 2017 | -111,000.00 |
| Dec 31, 2017 | -111,000.00 |
| Sep 30, 2017 | 764,000.00 |
| Sep 30, 2017 | 764,000.00 |
| Jun 30, 2017 | 272,000.00 |
| Jun 30, 2017 | 272,000.00 |
| Mar 31, 2017 | -718,000.00 |
| Mar 31, 2017 | -718,000.00 |